Anthem (ANTM) Raises Quarterly Dividend 7.1% to $0.75; 1.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Caribou Biosciences to halt CAR-T programs, explore sale
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Sportradar to sell Synergy Sports coaching unit for $170M
Anthem (ANTM) Appoints Bahija Jallal to Board
January 31, 2018 6:07 AM ESTAnthem, Inc. (NYSE: ANTM) announced today that Bahija Jallal, PhD, has been named to its Board of Directors effective February 1, 2018.
With more than 25 years of leadership experience and expertise in the biopharmaceutical industry, Dr. Jallals science-driven leadership combined with her passion to improve the lives of patients will be an asset to Anthems Board as they guide the Company... More
Anthem (ANTM) Tops Q4 EPS by 2c
January 31, 2018 6:05 AM ESTAnthem (NYSE: ANTM) reported Q4 EPS of $1.29, $0.02 better than the analyst estimate of $1.27. Revenue for the quarter came in at $22.4 billion versus the consensus estimate of $22.25 billion.
We are pleased with our 2017 performance, which is the result of improved execution in all areas of our business and an increased focus on... More



